Literature DB >> 18294862

Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure.

Robert M Carey1, Shetal H Padia.   

Abstract

The renin-angiotensin system is a coordinated hormonal cascade of crucial importance in cardiovascular and renal function. The primary effector peptide angiotensin II functions at two major receptors, the AT1 and AT2 receptors. AT2 receptors mediate vasodilation and natriuresis. Regarding vasodilator actions, AT2 receptors oppose the AT1 receptor-mediated vasoconstrictor action of angiotensin II. Regarding the natriuretic actions of AT2 receptors, des-aspartyl 1-angiotensin II, rather than angiotensin II, is the preferred agonist. Regarding both the vasodilator and natriuretic properties of AT2 receptors, the beneficial blood pressure reduction and natriuretic responses to AT1 receptor blockade are mediated, at least in part, by AT2 receptor activation. In addition, AT2 receptor activation suppresses renin biosynthesis and release at renal juxtaglomerular cells. Therefore, AT2 receptors are potential therapeutic targets in hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18294862     DOI: 10.1016/j.tem.2008.01.003

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  29 in total

1.  Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats.

Authors:  Jian Yang; Caiyu Chen; Hongmei Ren; Yu Han; Duofen He; Lin Zhou; Ulrich Hopfer; Pedro A Jose; Chunyu Zeng
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

2.  The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke.

Authors:  John S Smeda; Noriko Daneshtalab
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-21       Impact factor: 6.200

3.  Antenatal glucocorticoid treatment alters Na+ uptake in renal proximal tubule cells from adult offspring in a sex-specific manner.

Authors:  Yixin Su; Jianli Bi; Victor M Pulgar; Jorge Figueroa; Mark Chappell; James C Rose
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-01

4.  High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.

Authors:  Preethi Samuel; Quaisar Ali; Rifat Sabuhi; Yonnie Wu; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-16

5.  Angiotensin II type 2 receptor-coupled nitric oxide production modulates free radical availability and voltage-gated Ca2+ currents in NTS neurons.

Authors:  Gang Wang; Christal G Coleman; Michael J Glass; Ping Zhou; Qi Yu; Laibaik Park; Josef Anrather; Virginia M Pickel; Costantino Iadecola
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-02-29       Impact factor: 3.619

Review 6.  Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update.

Authors:  Sanket N Patel; Naureen Fatima; Riyasat Ali; Tahir Hussain
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

7.  GPCRs as potential therapeutic targets in preeclampsia.

Authors:  Jt McGuane; Kp Conrad
Journal:  Drug Discov Today Dis Models       Date:  2012-07-12

8.  Association of angiotensin II type I and type II receptor genes polymorphisms with the presence of premature coronary disease and metabolic syndrome.

Authors:  Tarek A Abd El-Aziz; Randa H Mohamed; Noha A Rezk
Journal:  Mol Biol Rep       Date:  2014-01-03       Impact factor: 2.316

9.  Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors.

Authors:  Brandon A Kemp; John F Bell; Daniele M Rottkamp; Nancy L Howell; Weijian Shao; L Gabriel Navar; Shetal H Padia; Robert M Carey
Journal:  Hypertension       Date:  2012-06-11       Impact factor: 10.190

Review 10.  Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.

Authors:  John J Gildea
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.